| Date | Time | Source | Announcement |
|---|---|---|---|
| 26 May 2021 | 04:41 PM | Second Price Monitoring Extn | |
| 26 May 2021 | 04:36 PM | Price Monitoring Extension | |
| 21 May 2021 | 07:00 AM | Results for the year ended 31 December 2020 | |
| 17 May 2021 | 02:06 PM | Second Price Monitoring Extn | |
| 17 May 2021 | 02:00 PM | Price Monitoring Extension | |
| 17 May 2021 | 11:06 AM | Second Price Monitoring Extn | |
| 17 May 2021 | 11:00 AM | Price Monitoring Extension | |
| 14 May 2021 | 10:50 AM | Cizzle Biotechnology/Bould (CIZ): Early detecti... | |
| 14 May 2021 | 07:00 AM | First Day of Dealings |
Cizzle Biotechnology Holdings engages in developing a blood test for the early detection of various forms of lung cancer. It develops CIZ1B protein gene and its potential as a diagnostic biomarker for detection and management of lung cancer.
CIZ share price listed at 9p in 2021.